Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents
NCT04461821 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3600
Last updated 2026-05-08
Summary
This study is to investigate breath analysis (breath metabolomics) combined with established bioinformatic tools as a platform for companion diagnostics.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Real-time SESI-MS breath analysis
Participants will be asked to refrain from eating, drinking, chewing gum use or brushing their teeth at least 1 hour before the measurements will be performed. Room temperature and lighting will be set at the same level for all measurements. Participants will exhale through a disposable mouthpiece into a commercially available SESI source (FIT S.L., Spain). While performing full exhalations, the subjects will keep the pressure through the sampling line at a fixed value monitored by a digital manometer. Breath prints will be collected in real-time recording multiple replicates (typically six in positive and negative ion mode). The whole procedure is absolutely non-invasive and is usually accomplished without any effort in around 15 min per subject.
- DIAGNOSTIC_TEST
-
Off-line breath analysis
In young children below the age of 4 not capable of completing the on-line exhalation maneuvers, or in cases when the patient needs cannot approach the mass spectrometer, the sample will be collected off-line. They will be asked to exhale into a bag that will be transported to the lab and deflated into the mass spectrometer for analysis. Exhaled breath of patients under anesthesia will also collected using available ventilation system in the operation theatre.
- DIAGNOSTIC_TEST
-
Blood analysis
Blood analysis done in patients who undergo regular blood sampling needed for clinical routine laboratory controls. This includes i) children and adolescents receiving medications which require TDM ii) patients with acute diseases such as TD1 and pneumonia and iii) patients with chronic diseases such as asthma bronchiale. For those patients where a blood sample is drawn during the clinical routine, an additional blood sample consisting of only several blood drops will be collected using the same blood sampling line. No additional venous puncture for research purpose will be done.
- DIAGNOSTIC_TEST
-
Saliva analysis
During the diagnostic and therapeutic work-up of T1D patients, saliva samples are collected during the clinical routine. For those patients, additional samples will be obtained by clinically trained investigators.
- DIAGNOSTIC_TEST
-
Urine analysis
During the diagnostic and therapeutic work-up of T1D patients, urine samples are collected during the clinical routine. For those patients, additional samples will be obtained by clinically trained investigators.
Sponsors & Collaborators
-
Swiss National Science Foundation
collaborator OTHER -
Fondation Botnar (Switzerland)
collaborator UNKNOWN -
University Children's Hospital Basel
lead OTHER
Principal Investigators
-
Pablo Sinues, Prof. Dr. · University Children's Hospital Basel
Eligibility
- Max Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-11
- Primary Completion
- 2030-07-31
- Completion
- 2030-07-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Reversibility of Bronchial Obstruction in Children Born Preterm
NCT06110481 ·Status: RECRUITING
-
Inhaled Corticosteroids After a Pediatric Emergency Visit for Asthma
NCT00294398 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Increasing Doses of Inhaled Albuterol in Children With Acute Wheezing Episodes
NCT01323010 ·Status: COMPLETED ·Phase: NA
-
Carbon Dioxide (CO2) Measurement With a CO2/O2 Guedel Airway
NCT03637257 ·Status: WITHDRAWN ·Phase: NA
-
Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis
NCT01619657 ·Status: COMPLETED ·Phase: PHASE2
-
Measurement of Respiratory Admittance for Pediatric Asthma Diagnosis
NCT02877537 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanical Insufflator/Exsufflator Technique in Children With Neuromuscular Disease
NCT05454215 ·Status: COMPLETED ·Phase: NA
-
Nebulised Hypertonic Saline in Children and Young People With Neuromuscular Disease and Cerebral Palsy
NCT03623698 ·Status: COMPLETED
-
Does the Coaching Function Improve the Learning of Mechanical In-exsufflation (MI-E) in Paediatric Subjects?
NCT06190431 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Inhaled Corticosteroids in Preschool Children With Acute Dyspnea and Wheeze
NCT00962299 ·Status: TERMINATED ·Phase: PHASE4
-
Inhaled Beclomethasone to Prevent Chronic Lung Disease
NCT00000576 ·Status: COMPLETED ·Phase: PHASE3
-
High Flow Nasal Cannula in Children With Status Asthmaticus
NCT03157102 ·Status: COMPLETED ·Phase: NA
-
Forced Inspiratory Flow Volume Curve in Healthy Young Children
NCT00533715 ·Status: COMPLETED
-
Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
NCT02528318 ·Status: TERMINATED ·Phase: PHASE2
-
Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma ?
NCT01239199 ·Status: COMPLETED ·Phase: NA
-
Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children
NCT03814954 ·Status: COMPLETED ·Phase: NA
-
Budesonide for Emergency Treatment of Acute Wheezing in Children
NCT00733317 ·Status: COMPLETED ·Phase: PHASE4
-
High Flow in Infants With Bronchiolitis
NCT02913040 ·Status: COMPLETED ·Phase: NA
-
The Effect of Bethanechol on Tracheobronchomalacia
NCT05299008 ·Status: RECRUITING
-
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
NCT00144846 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Magnesium in Wheezy Bronchitis
NCT01383655 ·Status: COMPLETED ·Phase: NA
-
Nebulized Adrenalin and Oral Betamethasone in Children With Bronchiolitis Attending Pediatric Emergencies.
NCT02586961 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Inhaled Budesonide in Transient Tachypnea of the Newborn
NCT04758078 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
NCT01035190 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age
NCT01649401 ·Status: COMPLETED ·Phase: NA